To reduce bruising and avoid lumps (lipohypertrophy) from GLP-1 injections, following a few straightforward techniques can make a noticeable difference
Have a BMI of 27 or higher WITH another health-related condition These conditions include diabetes, sleep apnea, & heart conditions like hypertension or hyperlipidemia
MT-IIs effects are mediated through central melanocortinergic pathways, with supraspinal and spinal mechanisms playing key roles
This protective effect is particularly important for people with obesity, who often face higher cardiovascular risks
Combines appetite suppression with increased metabolic rate from glucagon agonism
Ophthalmology (Dedicated Focus via Eyconis) In 2024, Ascendis Pharma partnered with Frazier Life Sciences and other investors to launch Eyconis, Inc., a new company dedicated to the global development and commercialization of TransCon ophthalmology products